Thoracic Research and Practice
Review

Can the Use of Smokeless Tobacco Products Be Accepted as a Harm Reduction Method in Tobacco Addiction?

1.

Department of Chest Diseases, Internal Medicine, Karadeniz Technical University Faculty of Medicine, Trabzon, Turkey

2.

Department of Chest Diseases, Internal Medicine, İnönü University Faculty of Medicine, Malatya, Turkey

3.

Department of Chest Diseases, Internal Medicine, Aydın University Faculty of Medicine, Aydın, Turkey

4.

Department of Chest Diseases, Internal Medicine, Dokuz Eylül University Faculty of Medicine, İzmir, Turkey

5.

Clinic of Chest Diseases, Dışkapı Training Hospital, Ankara, Turkey

6.

Department of Chest Diseases, Internal Medicine, Başkent University Faculty of Medicine, Ankara, Turkey

7.

Retired Academician, Marmara University Faculty of Medicine, İstanbul, Turkey

Thorac Res Pract 2014; 15: 136-141
DOI: 10.5152/ttd.2014.3875
Read: 2167 Downloads: 1270 Published: 18 July 2019

Abstract

The goal of smoking cessation treatment is to keep the patient completely away from tobacco and tobacco products. The aim of harm reduction strategies in tobacco control is to reduce the risks associated with tobacco use. In order to turn it into an opportunity, tobacco companies have developed smokeless tobacco products. Some epidemiological studies have reported that smokeless tobacco products are safer than tobacco smoke. However, this method is not completely harmless. In this review, we will discuss all aspects of tobacco harm reduction methods. 

Files
EISSN 2979-9139